NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR
INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY
OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE
UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE
SECURITIES DESCRIBED HEREIN.

Oslo, 28 June 2022:  Statt Torsk ASA ("Statt Torsk" or the "Company") has
retained SpareBank 1 Markets AS as Lead Manager and Sole Bookrunner, and Danske
Bank, Norwegian branch as Co-Lead Manager (together the "Managers") to advise on
and effect a contemplated private placement of new ordinary shares in the
Company (the "Offer Shares") to raise gross proceeds of approximately NOK 26.7 -
50 million (the "Private Placement"). The subscription price per Offer Share in
the Private Placement (the "Subscription Price") will be NOK 2.0 per share.

The net proceeds from the Private Placement will be used to finance build-up of
biomass to facilitate year-round delivery of farmed cod from H2 2022 (and is
expected to be sufficient till the Company reaches this milestone), and for
general corporate purposes.

The following close associates to the Company's Board of Directors (the "Board")
have pre-committed to subscribe for and be allocated shares for approx. NOK 10
million:

(*) TD Veen AS, a company associated with member of the Board, Øyvind Schanke,
has pre-committed to subscribe for Offer Shares for NOK 5.0 million.

(*) Orinoco AS, a company controlled by the chairman of the Board, Nicolas
Brun-Lie, has pre-committed to subscribe for Offer Shares for NOK 5.0 million.

The following close associates to the Board and management have pre-committed to
subscribe for and be allocated shares in the Private Placement for approx. NOK
6.7 million through conversion of a credit facility entered into on 11 May 2022
(the "Credit Facility Conversion"):

(*) Orinoco AS, a company controlled by the chairman of the Board, Nicolas
Brun-Lie, has pre-committed to subscribe for Offer Shares for NOK 5.0 million
through the Credit Facility Conversion.

(*) Medvode AS, a company controlled by CEO, Gustave Brun-Lie, has pre-committed
to subscribe for Offer Shares for NOK 1.0 million through the Credit Facility
Conversion.

(*) Mami Holding AS, a company controlled by member of the Board, Marianne
Kveldstad, has pre-committed to subscribe for Offer Shares for NOK 0.7 million
through the Credit Facility Conversion.

The outstanding principal amount under the credit facility will be approx. NOK
4.0 million after the Private Placement.

In addition, based on a limited market sounding exercise prior to launch, the
Managers has received indications of interest to subscribe for Offer Shares so
that the total amount of pre-commitments and indications of interest exceeds the
minimum deal size at the start of the application period.

The application period in the Private Placement will commence today, on 28 June
2022 at 16:30 CEST and close on 29 June 2022 at 08:00 CEST. The Managers and the
Company may, however, at any time resolve to shorten or extend the application
period on short or without notice. If the application period is shortened or
extended, any other dates referred to herein may be amended accordingly.

The Private Placement will be directed towards selected Norwegian and
international investors (a) outside the United States in reliance on Regulation
S under the U.S, Securities Act of 1933, as amended (the "U.S. Securities Act"),
and (b) to investors in the United States who are "qualified institutional
buyers" ("QIBs") as defined in Rule 144A under the U.S. Securities Act, in each
case subject to an exemption being available from prospectus requirements and
any other filing or registration requirements in the applicable jurisdictions
and subject to other selling restrictions. The minimum application and
allocation amount has been set to the NOK equivalent of EUR 100,000 per
investor. The Company may, however, at its sole discretion, allocate an amount
below EUR 100,000 to the extent applicable exemptions from the prospectus
requirements pursuant to the Norwegian Securities Trading Act and ancillary
regulations are available, including to employees and directors of the Company
and the Company group. Further selling restrictions and transaction terms will
apply.

Allocation of Offer Shares will be determined at the end of the application
period by the Board in consultation with the Managers, at its sole discretion.
The Company may focus on allocation criteria such as (but not limited to)
existing ownership in the Company, timeliness of the application, relative order
size, sector knowledge, investment history, perceived investor quality and
investment horizon.

Settlement is expected to take place on or about 1 July 2022 on a delivery
versus payment (DVP) basis. Delivery of the Offer Shares allocated in the
Private Placement will, in order to facilitate DVP settlement, be made by
delivery of existing and unencumbered shares in the Company already admitted to
trading on Euronext Growth Oslo, pursuant to a share lending agreement (the
"Share Lending Agreement") to be entered into between the Company, the Managers
and Orinoco AS, a close associate of our chairman, Nicolas Brun-Lie. The
Managers will settle the share loan with new shares in the Company to be issued
by the Board pursuant to an authorisation granted by the Company's General
Meeting held on 20 December 2021.

Completion of the Private Placement is subject to all necessary corporate
resolutions being validly made by the Company, including without limitation, the
Board resolving to consummate the Private Placement and issue and allocate the
Offer Shares.

The Company reserves the right, at any time and for any reason, to cancel,
and/or modify the terms of, the Private Placement prior to completion. Neither
the Company nor the Managers will be liable for any losses incurred by
applicants if the Private Placement is cancelled, irrespective of the reason for
such cancellation.

The Company has considered the Private Placement in light of the equal treatment
obligations under the Norwegian Securities Trading Act and Oslo Børs' Circular
no. 2/2014 and is of the opinion that the waiver of the shareholders'
preferential rights inherent in a private placement, taking into consideration
the time, costs, and risk of alternative methods of the securing the desired
funding is in the common interest of the shareholders of the Company. By
structuring the equity raise as a private placement, the Company is expected to
raise equity efficiently, with a lower discount to the current trading price, at
a lower cost and with a significantly lower risk compared to a rights issue. It
has also been taken into consideration that the Private Placement is based on a
publicly announced bookbuilding process. Further, the Offer Price in the Private
Placement represents limited discount compared to the closing trading price of
the Company's share as of 28 June 2022. Based on the foregoing, the limited
dilution of the Private Placement, and the costs and risks for completing a
subsequent repair offering, it is currently not planned to conduct a subsequent
repair issue directed towards shareholders not participating in the Private
Placement. 

SpareBank 1 Markets AS is acting as Lead Manager and Sole Bookrunner, and Danske
Bank, Norwegian Branch is acting as Co-Lead Manager in connection with the
Private Placement. Ro Sommernes is acting as legal advisor to the Company and
Advokatfirmaet Wiersholm AS is acting as legal advisor to the Managers.

This information is considered to be inside information pursuant to the EU
Market Abuse Regulation and is subject to the disclosure requirements pursuant
to Section 5-12 the Norwegian Securities Trading Act. This stock exchange notice
was published by Bjug Borgund, CFO of the Company, on 28 June 2022 at 16:30
CEST.

For more information